Colossal Biosciences in Talks for New Funding at $20B–$30B Valuation
De-extinction startup Colossal Biosciences is reportedly seeking a valuation of between $20 billion and $30 billion as it raises new capital. The company, which has begun generating revenue through conservation technology sales to governments like the UAE and plans for multiple spin-offs, aims to expand its operations in genetic research and biotechnology.
Topics: biotech capital raising de-extinction startup valuation